Halozyme Therapeutics, Inc. (HALO)
108.64
+0.47
(+0.43%)
USD |
NASDAQ |
Aug 24, 16:00
108.64
0.00 (0.00%)
After-Hours: 19:20
Halozyme Therapeutics Market Cap : 12.39B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 12.34B |
| August 20, 2026 | 12.10B |
| August 19, 2026 | 12.27B |
| August 18, 2026 | 11.96B |
| August 17, 2026 | 11.75B |
| August 14, 2026 | 11.25B |
| August 13, 2026 | 11.48B |
| August 12, 2026 | 11.61B |
| August 11, 2026 | 11.70B |
| August 10, 2026 | 11.70B |
| August 07, 2026 | 11.76B |
| August 06, 2026 | 9.780B |
| August 05, 2026 | 9.533B |
| August 04, 2026 | 9.492B |
| August 03, 2026 | 9.751B |
| July 31, 2026 | 9.783B |
| July 30, 2026 | 9.873B |
| July 29, 2026 | 9.871B |
| July 28, 2026 | 9.890B |
| July 27, 2026 | 9.657B |
| July 24, 2026 | 9.711B |
| July 23, 2026 | 9.581B |
| July 22, 2026 | 9.223B |
| July 21, 2026 | 9.316B |
| July 20, 2026 | 9.137B |
| Date | Value |
|---|---|
| July 17, 2026 | 9.222B |
| July 16, 2026 | 9.190B |
| July 15, 2026 | 8.986B |
| July 14, 2026 | 8.895B |
| July 13, 2026 | 9.021B |
| July 10, 2026 | 9.031B |
| July 09, 2026 | 9.318B |
| July 08, 2026 | 9.526B |
| July 07, 2026 | 9.668B |
| July 06, 2026 | 9.574B |
| July 02, 2026 | 9.417B |
| July 01, 2026 | 9.127B |
| June 30, 2026 | 9.277B |
| June 29, 2026 | 9.148B |
| June 26, 2026 | 8.884B |
| June 25, 2026 | 8.609B |
| June 24, 2026 | 8.433B |
| June 23, 2026 | 8.252B |
| June 22, 2026 | 8.177B |
| June 18, 2026 | 8.125B |
| June 17, 2026 | 8.127B |
| June 16, 2026 | 8.254B |
| June 15, 2026 | 8.448B |
| June 12, 2026 | 8.237B |
| June 11, 2026 | 8.383B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Incyte Corp. | 25.72B |
| Neurocrine Biosciences, Inc. | 15.55B |
| AVITA Medical, Inc. | 306.79M |
| Agenus, Inc. | 326.86M |
| Amgen, Inc. | 239.94B |
Market Cap Related Metrics
| PE Ratio | 32.46 |
| PS Ratio | 7.903 |
| Price to Book Value | 86.31 |
| Price to Free Cash Flow | 16.31 |
| Price | 108.64 |
| Earnings Yield | 3.08% |
| Operating PE Ratio | 13.92 |
| Normalized PE Ratio | 19.95 |